D S Postma Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

12/2007	Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study.
06/2007	Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.
01/2007	Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression?
07/2006	High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function.
12/2005	Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
11/2005	[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial]
06/2005	Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
04/2004	Haem oxygenase-1 expression is diminished in alveolar macrophages of patients with COPD.
06/2002	Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.
06/2002	Provocation with adenosine 5'-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease.
10/2000	Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study.
09/2000	Borg scores before and after challenge with adenosine 5'-monophosphate and methacholine in subjects with COPD and asthma.
05/2000	Airway inflammation and hyperresponsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease.
01/2000	Ongoing airway inflammation in patients with COPD who do not currently smoke.

Articles by Research Topic

Disease

21	Asthma (Bronchial Asthma) 09/2008 - 07/2000
14	Chronic Obstructive Pulmonary Disease (COPD) 12/2007 - 01/2000
8	Inflammation 12/2007 - 01/2000
2	Hypersensitivity (Allergy) 09/2002 - 09/2001
2	Bronchiolitis Obliterans 12/2000 - 06/2000
2	Syndrome 12/2000 - 06/2000
1	Necrosis 01/2007
1	Eosinophilia 01/2004
1	Rhinitis 06/2002
1	Airway Obstruction (Choking) 02/2001
1	Bronchiolitis 12/2000

Drug/Important Bio-Agent (IBA)

6	Adenosine FDA LinkGeneric 01/2004 - 05/2000
4	fluticasone (Cutivate)FDA LinkGeneric 11/2005 - 12/2001
4	Methacholine Chloride (Methacholine)FDA Link 01/2004 - 09/2000
3	Budesonide (Pulmicort)FDA LinkGeneric 06/2007 - 06/2001
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2006 - 12/2005
2	ciclesonide FDA Link 06/2008 - 06/2001
2	salmeterol (Serevent)FDA Link 11/2005 - 06/2005
2	SmokeIBA 08/2004 - 01/2000
2	formoterol (Oxis)FDA Link 06/2001 - 01/2001
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2008
1	Carbon MonoxideIBA 12/2007
1	OvalbuminIBA 12/2007
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2005
1	Heme (Haem)IBA 04/2004
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2003
1	Immunologic Factors (Immunomodulators)IBA 09/2002
1	Dust (House Dust)IBA 09/2002
1	Eosinophil Cationic ProteinIBA 07/2002
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2002
1	Phenobarbital (Luminal)FDA Link 01/2002
1	Adenosine Monophosphate (AMP)IBA 10/2001
1	Interleukin-13IBA 09/2001
1	N- ((3- (aminomethyl)phenyl)methyl)etnanimidamideIBA 09/2001
1	acetovanillone (apocynin)IBA 09/2001
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 02/2001
1	SR 48968 (saredutant)IBA 02/2001
1	Terbutaline (Brethaire)FDA LinkGeneric 01/2001
1	Interleukin-6 (Interleukin 6)IBA 12/2000
1	Immunoglobulin E (IgE)IBA 11/2000
1	Histamine (Histamine Dihydrochloride)IBA 10/2000
1	CytokinesIBA 07/2000
1	Cyclic AMP (AMP, Cyclic)IBA 07/2000

Therapy/Procedure

3	Lung Transplantation 12/2000 - 06/2000